Clinical Trial Update: Comparison Between Bilateral Infraorbital Block Versus Intranasal Bupivacaine in Transsphenoidal Pituitary Adenoma Resection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing bilateral infraorbital block with intranasal bupivacaine for transsphenoidal pituitary adenoma resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Adenoma

Drugs mentioned

• Bupivacaine (Bupivacaine)

Snippet

Sponsor: Cairo University | Conditions: Intraoperative Hypertension | Phase 3 | Status: COMPLETED